PDF(524 KB)
Repeated measures-based comparison of patient-reported outcomes for patients with hypertension having different medication regimens and blood pressure levels
Tang Shunding, Zhang Wen, Deng Li, Song Ying, Wang Han, Zhang Xiaoqing, Zhang Ru
PDF(524 KB)
PDF(524 KB)
Repeated measures-based comparison of patient-reported outcomes for patients with hypertension having different medication regimens and blood pressure levels
Objective To compare the therapeutic effects of different medication regimens in patients with hypertension with different blood pressure levels based on patient reported outcomes（PROs），and to provide a reference for clinicians to choose medication regimens. Methods A total of 625 community patients with hypertension who were taking antihypertensive medications underwent a baseline PRO measure and three repeated-measures of PRO（once every three months）. Repeated-measures analysis of variance （ANOVA） was used to compare the PRO of six combinations generated with two medication regimens（single medications and combined medications） and three blood pressure levels（grade-1 hypertension，grade-2 hypertension，and grade-3 hypertension） at different time points. Results Repeated-measures ANOVA results showed that patients with hypertension having different medication regimens and blood pressure levels had varying degrees of fluctuations in PRO scores across three repeated measures. For patients with grade-1 hypertension on single medications，PRO scores in physical health，mental health，social health，spiritual/faith-related health，and the specific module fluctuated downward. For both patients with grade-2 hypertension and those with grade-3 hypertension on single medications，the scores in mental health，social health，and spiritual/faith-related health fluctuated upward. There were no significant differences in PRO scores in physical health among grade-1，-2，and -3 hypertensive patients on combined medications. There was a downward trend in mental health-related PRO score in patients with grade-2 hypertension on combined medications. The PRO score in social health showed a fluctuating upward trend in patients with grade-3 hypertension on combined medications. For patients with grade-1 hypertension and those with grade-2 hypertension on combined medications，the PRO score in spiritual/faith-related health fluctuated downward and upward，respectively. There was a downward trend in the specific module score of patients with grade-2 hypertension on combined medications. The total PRO score declined in patients with grade-1 hypertension and fluctuated upward in patients with grade-2 and grade-3 hypertension，regardless of single or combined medications. Conclusion Patients with different grades of hypertension have varying PRO scores with single and combined medications，and clinicians can refer to patients’ PROs when choosing medication regimens.
hypertension / patient-reported outcome / medication regimen
| 1 |
《中国心血管健康与疾病报告2021》编写组. 《中国心血管健康与疾病报告2021》概述[J]. 中国心血管病研究，2022，20（7）：577-596．
The Writing Committee of the Report on Cardiovascular Health and Diseases in China 2021. Key points of Report on Cardiovascular Health and Diseases in China 2021[J]. Chin J Cardiovasc Res，2022，20（7）：577-596．
|
| 2 |
|
| 3 |
隆莉芝，袁 玲. 患者报告结局的应用近况及思考[J]. 中国全科医学，2020，23（32）：4120-4127．
|
| 4 |
Department of Health and Human Services FDA Center for Drug Evaluation and Research US，Department of Health and Human Services FDA Center for Biologics Evaluation and Research US，Department of Health and Human Services FDA Center for Devices and Radiological Health US ．Guidance for industry：patient-reported outcome measures：use in medical product development to support labeling claims：draft guidance[J]. Health Qual Life Outcomes，2006，4：79．
|
| 5 |
周 慧，林 颖，周国进，等. 《将患者报告结局纳入临床研究的伦理考量：PRO伦理指南》解读[J]. 中国全科医学，2023，26（4）：395-400．
|
| 6 |
|
| 7 |
《中国高血压防治指南》修订委员会. 中国高血压防治指南（2018年修订版）[J]. 中国心血管杂志，2019，24（1）：24-56．
Writing Group of Chinese Guidelines for the Management of Hypertension. 2018 Chinese guidelines for the management of hypertension[J]. Chin J Cardiovasc Med，2019，24（1）：24-56．
|
| 8 |
国家卫生计生委合理用药专家委员会，中国医师协会高血压专业委员会. 高血压合理用药指南（第2版）[J]. 中国医学前沿杂志（电子版），2017，9（7）：28-126．
Expert Committee on Rational Use of Medicines of the National Health and Family Planning Commission，Hypertension Specialized Committee of China Medical Doctors Association. Guidelines for rational drug use in hypertension （2nd edition）[J]. Chin J Front Med Sci Electron Version，2017，9（7）：28-126．
|
| 9 |
|
| 10 |
史 钊，窦 蕾，李顺平. 国内外患者报告结局的应用现状与研究进展[J]. 中国全科医学，2023，26（4）：401-408．
|
| 11 |
曹 阳，余小萍. PRO 量表国内外研究近况[J]. 中医杂志，2014，55（8）：710-714．
|
| 12 |
彭丽霞，张 勇. 高血压患者报告结局的研究现状[J]. 保健医学研究与实践，2021，18（1）：100-104．
|
| 13 |
|
/
| 〈 |
|
〉 |
AI Summary
